RADIOTHERAPY AND ONCOLOGY
Scope & Guideline
Empowering oncology with innovative radiotherapy insights.
Introduction
Aims and Scopes
- Clinical Radiotherapy Techniques:
The journal publishes studies on various radiotherapy techniques, including intensity-modulated radiotherapy (IMRT), stereotactic body radiotherapy (SBRT), and brachytherapy. Research in this area focuses on optimizing treatment plans, improving delivery methods, and assessing patient outcomes. - Radiobiology and Treatment Response:
It covers the biological effects of radiation on cancer cells and surrounding tissues. This includes studies on dose-response relationships, mechanisms of radioresistance, and the role of biomarkers in predicting treatment efficacy. - Technological Innovations in Radiotherapy:
The journal highlights advancements in radiotherapy technology, such as MR-guided therapy, artificial intelligence applications in treatment planning, and the development of new imaging techniques to improve accuracy and precision in radiation delivery. - Quality Assurance and Safety in Radiotherapy:
Research related to quality assurance processes, patient safety protocols, and the implementation of best practices in radiotherapy settings is a significant focus area, aiming to minimize errors and enhance treatment quality. - Patient-Reported Outcomes and Quality of Life:
The journal emphasizes the importance of patient-reported outcomes and quality of life assessments in cancer treatment. It aims to understand the impact of radiotherapy on patients' physical, emotional, and social well-being. - Palliative Care and Symptom Management:
It addresses the role of radiotherapy in palliative care settings, exploring its effectiveness in managing symptoms and improving the quality of life for patients with advanced cancer.
Trending and Emerging
- Artificial Intelligence in Radiotherapy:
There is a significant increase in research exploring the application of artificial intelligence (AI) in various aspects of radiotherapy, including treatment planning, image analysis, and patient-specific quality assurance. AI's potential to enhance precision and efficiency in radiation therapy is a major focus. - Personalized and Adaptive Radiotherapy:
Emerging studies emphasize the need for personalized treatment approaches, including adaptive radiotherapy that adjusts for anatomical changes over the course of treatment, aiming to optimize therapeutic outcomes and minimize toxicity. - Integration of Immunotherapy with Radiotherapy:
Research is increasingly focusing on the synergistic effects of combining immunotherapy with radiotherapy, investigating how these modalities can enhance treatment response and improve patient survival rates. - Longitudinal Patient-Reported Outcomes:
There is a growing emphasis on longitudinal studies assessing patient-reported outcomes (PROs) and quality of life, recognizing the importance of these metrics in evaluating the overall effectiveness of radiotherapy. - Radiomics and Biomarker Development:
The trend towards utilizing radiomics—extracting large amounts of features from medical images—and developing predictive biomarkers for treatment response is gaining momentum, with potential applications in personalized treatment strategies. - Sustainability and Cost-Effectiveness in Radiotherapy:
Emerging research focuses on the sustainability of radiotherapy practices and the economic evaluation of treatment strategies, aiming to balance efficacy with cost-effectiveness in healthcare delivery.
Declining or Waning
- Traditional Radiotherapy Techniques:
There has been a noticeable decline in studies focusing solely on conventional radiotherapy techniques, such as 2D planning and standard fractionation, as newer, more advanced methods gain traction in clinical practice. - Single-Agent Radiotherapy Studies:
Research that investigates the effects of radiotherapy as a standalone treatment has seen a decrease. There is a growing emphasis on combination therapies, particularly integrating radiotherapy with immunotherapy or targeted therapies. - Basic Radiobiological Studies:
While foundational research in radiobiology remains important, there is a shift towards more applied research that directly correlates with clinical outcomes, leading to a reduction in purely theoretical studies. - Generalized Quality Assurance Protocols:
The focus on generalized quality assurance protocols has waned in favor of more specific, customizable approaches tailored to individual patient needs and treatment plans.
Similar Journals
SEMINARS IN RADIATION ONCOLOGY
Connecting Researchers and Clinicians for Better OutcomesSEMINARS IN RADIATION ONCOLOGY is a premier journal published by W B SAUNDERS CO-ELSEVIER INC, dedicated to advancing the field of radiation oncology through high-quality research and comprehensive reviews. With an impressive impact factor and a notable HIndex, this journal holds a prominent place within the academic community, particularly illustrated by its Q2 ranking in both Cancer Research and Oncology, and a Q1 ranking in Radiology, Nuclear Medicine, and Imaging as of 2023. Since its inception in 1991, the journal has served as a vital resource for researchers, clinicians, and healthcare professionals, facilitating the exchange of innovative ideas and practices that shape the future of cancer treatment. While the journal is not open access, it offers essential insights into the latest advancements in the field, catering to a diverse audience eager to expand their knowledge and improve patient outcomes in the realm of radiation therapy.
Onkologija
Connecting researchers and practitioners in the battle against cancer.Onkologija is a distinguished open-access journal dedicated to the field of oncology, published by the Institute of Oncology Ljubljana. With its ISSN 1408-1741 and E-ISSN 1581-3215, this journal has become a crucial platform for researchers and healthcare professionals since its transition to open-access in 2008, allowing widespread dissemination of critical findings and innovations in cancer research and treatment. Located in Ljubljana, Slovenia, the journal aims to bridge the gap between clinical practice and research by publishing high-quality original articles, reviews, and case studies that address pivotal issues in oncology. Although specific metrics such as HIndex and Scopus ranks are currently unavailable, Onkologija’s commitment to advancing oncology knowledge is evident in its engaging publications that attract a diverse readership, making it an essential resource for anyone invested in the battle against cancer.
Translational Oncology
Advancing Cancer Research from Lab to LifeTranslational Oncology is a premier open access journal published by Elsevier Science Inc, dedicated to the rapidly evolving field of cancer research and oncology. Since its inception in 2008, the journal has been a vital platform for the dissemination of innovative research and findings that bridge the gap between laboratory discoveries and clinical applications. With an impressive impact factor and ranked Q2 in Cancer Research and Q1 in Oncology, it occupies a prominent position in the academic landscape, helping to shape the future of cancer therapeutics and patient care. The journal offers valuable insights across a diverse array of topics, including molecular biology, genetic factors in cancer, and innovative treatment strategies, ensuring relevance and engagement for its readership. As it converges toward 2024, Translational Oncology continues to attract a global audience of researchers, healthcare professionals, and students committed to advancing our understanding of cancer and enhancing clinical outcomes.
Advances in Radiation Oncology
Pioneering Tomorrow's Cancer TreatmentsAdvances in Radiation Oncology, published by Elsevier Inc, is a premier international journal dedicated to the field of oncology and radiology, focusing on the latest groundbreaking research and innovations in radiation therapy. Launched as an Open Access journal in 2016, it has since carved out a significant niche in the academic community, featuring contributions that span a diverse range of topics including clinical practices, technologies, and outcomes in radiation oncology. With an impressive Q2 rankingOncology and Radiology, Nuclear Medicine and Imaging categories for 2023, and positioned within the 65th and 55th percentiles of Scopus ranks, it serves as an essential resource for researchers, medical professionals, and students alike. The journal not only emphasizes the importance of disseminating knowledge widely through its open access model but also aims to foster collaboration and innovation in the evolving landscape of cancer treatment. For those looking to stay at the forefront of radiotherapy research and advancements, Advances in Radiation Oncology is an invaluable platform for scholarly communication.
JOURNAL OF RADIATION RESEARCH
Exploring the frontiers of health and toxicology in radiation.JOURNAL OF RADIATION RESEARCH, published by Oxford University Press, is a prominent peer-reviewed journal focusing on the diverse fields of radiation science, including health, toxicology, and radiology. Since its inception in 1960, this open-access journal has provided a critical platform for the dissemination of high-quality research, making it accessible to a global audience of researchers, professionals, and students. With a consistent track record, the journal holds an impressive impact factor and is categorized in Q2 of Radiation studies and Q3 in Health and Toxicology as per the 2023 rankings, reflecting its influential role in shaping contemporary discourse in the field. The journal also boasts notable rankings within Scopus, further underscoring its importance in advancing knowledge and innovations related to radiation. Spanning from 1960 to 2024, the JOURNAL OF RADIATION RESEARCH remains at the forefront of scientific exploration and is essential reading for anyone committed to advancing the understanding of radiation and its effects.
Turk Onkoloji Dergisi-Turkish Journal of Oncology
Shaping the future of oncology with dedicated research and expertise.Turk Onkoloji Dergisi - Turkish Journal of Oncology, published by KARE PUBL, serves as a vital platform in the field of oncology, specifically catering to the Turkish-speaking research community and contributing to global discourse. With an ISSN of 1300-7467, this journal, which has been in circulation since 2007 and continues until 2024, recognizes the importance of advancing medical knowledge in cancer research through rigorous peer-reviewed articles. Although currently positioned in the Q4 category of oncology journals with a Scopus rank of #344 out of 404, the journal is dedicated to fostering significant research insights and innovative perspectives on cancer treatment and prevention. While it does not currently offer open access, its content is essential for professionals, researchers, and students aiming to enhance their understanding of oncology developments in Turkey and beyond. The Turkish Journal of Oncology not only aspires to improve the quality of cancer care but also strives to enhance collaboration among researchers, thereby influencing future oncology practices.
Physics & Imaging in Radiation Oncology
Exploring New Frontiers in Radiation Therapy and ImagingPhysics & Imaging in Radiation Oncology is a premier journal dedicated to advancing the interdisciplinary field of radiation oncology through innovative research and imaging technologies. Published by Elsevier, this open-access journal has made its mark since its inception in 2017, ensuring that groundbreaking findings are accessible to a broad audience. With a strong focus on the integration of physics, imaging techniques, and oncology, the journal occupies esteemed positions in the academic landscape, ranking in the top quartile for Radiation and Radiology, Nuclear Medicine and Imaging as of 2023. The journal serves as a platform for researchers, professionals, and students to share insights and foster collaboration, ultimately improving patient outcomes through enhanced imaging and treatment modalities. Based in Ireland and operating from Radarweg 29, 1043 NX Amsterdam, Netherlands, the journal aims to bridge the gap between theoretical physics and practical applications in clinical settings.
STRAHLENTHERAPIE UND ONKOLOGIE
Unveiling the future of cancer treatment and radiation therapy.STRAHLENTHERAPIE UND ONKOLOGIE is an esteemed journal published by Springer Heidelberg, focusing on critical advancements and research in the fields of Oncology and Radiology. Established in 1986, this journal has carved its niche within the scientific community, ranking in the Q1 category for Radiology, Nuclear Medicine and Imaging, and Q2 for Oncology as of 2023. With an ISSN of 0179-7158 and E-ISSN 1439-099X, it serves as an essential resource for researchers, professionals, and students dedicated to the complexities of cancer treatment and radiation therapy. While the journal operates under a subscription model, its broad international readership values its rigorous peer-review process and comprehensive coverage of pivotal studies. STRAHLENTHERAPIE UND ONKOLOGIE continues to enhance its impact in the domains of oncology and radiology, as evidenced by its commendable Scopus rankings, including a 76th percentile in Radiology and a 65th percentile in Oncology. Its commitment to disseminating innovative research solidifies its role as a cornerstone in the ongoing quest to improve patient care and therapeutic techniques.
Radiological Physics and Technology
Pioneering discoveries in medical imaging.Radiological Physics and Technology, published by SPRINGER JAPAN KK, is a prominent journal that serves as a crucial resource in the multidisciplinary fields of medicine and radiation sciences. With an ISSN of 1865-0333 and an E-ISSN of 1865-0341, the journal has been converging impactful research from 2008 to 2024. It holds a commendable position in academic rankings, currently classified in Q2 in Physical Therapy, Sports Therapy and Rehabilitation and Radiation, along with Q3 for Medicine (miscellaneous) and Radiology, Nuclear Medicine and Imaging. The journal is well-regarded in the academic community, reflected in its Scopus rankings that place it in the upper tiers of its respective categories. Although it currently does not offer Open Access, Radiological Physics and Technology remains a pivotal publication for researchers, academics, and practitioners seeking to advance knowledge and foster innovation in radiological science. Its commitment to disseminating high-quality research ensures its continued relevance and importance within these fields.
Journal of Radiotherapy in Practice
Fostering Collaborative Research for Enhanced Patient OutcomesJournal of Radiotherapy in Practice is a peer-reviewed journal published by Cambridge University Press, focusing on the evolving field of radiotherapy and its application in clinical practice. With ISSN 1460-3969 and E-ISSN 1467-1131, this journal serves as a critical platform for researchers, clinicians, and students in oncology and radiology, providing vital insights into treatment methodologies, patient care, and innovative practices. Although indexed in Q4 quartiles for both Oncology and Radiology, Nuclear Medicine and Imaging, the journal plays an essential role in disseminating clinical findings and advancing the science of radiotherapy since its inception in 1999. Authors are encouraged to contribute their research, case studies, and reviews that align with the journal's objectives, fostering a collaborative environment for sharing knowledge. Despite its current rankings, the journal aims to enhance its impact and visibility in the scientific community, thereby enriching professional practice and patient outcomes in the realm of radiotherapy.